Core Viewpoint - The legal opinion letter from Grandall Law Firm (Xi'an) confirms that Shaanxi Srey New Materials Co., Ltd. has obtained the necessary approvals and authorizations for its 2023 stock option incentive plan adjustments, ensuring compliance with relevant laws and regulations [1][5][9] Group 1: Legal Framework and Compliance - The law firm was appointed as a special legal advisor for the 2023 stock option incentive plan of Shaanxi Srey New Materials Co., Ltd. [1] - The legal opinion is based on various laws including the Company Law, Securities Law, and relevant regulations from the Shanghai Stock Exchange [1][4] - The firm confirms that the company provided all necessary and accurate documentation for the legal opinion [4][5] Group 2: Approval and Authorization - The adjustments to the stock option incentive plan have received necessary approvals from the board and supervisory committee [6][7] - The company has publicly disclosed the list of incentive recipients and received no objections during the public notice period [6][7] - The board approved the adjustment of the exercise price for the stock options to 9.70 yuan per share [9] Group 3: Specific Adjustments - The adjustments to the stock option plan were made in response to the company's cash dividend distribution, which amounted to 29.17 million yuan [8] - The exercise price was adjusted from 9.74 yuan to 9.70 yuan per share following the dividend distribution [9] - The adjustments comply with the provisions of the incentive plan and relevant regulations [9]

Core Viewpoint - The legal opinion letter outlines the approval and authorization process for the 2024 stock option incentive plan of Shenzhen Haon Automotive Electronics Equipment Co., Ltd, including the granting of reserved stock options, adjustment of exercise prices, and cancellation of unexercised stock options due to unmet performance conditions [1][6][11]. Group 1: Approval and Authorization - The company held its third board meeting on July 11, 2024, where it approved the stock option incentive plan and related proposals [3]. - The third supervisory board meeting on the same day also approved the incentive plan and confirmed the eligibility of the incentive objects [3]. - The company announced the list of incentive objects on July 13, 2024, confirming their compliance with relevant laws and regulations [3]. - The third extraordinary general meeting of shareholders on July 29, 2024, authorized the board to implement the incentive plan [3]. - On August 2, 2024, the board approved the initial grant of 3.581 million stock options to 200 incentive objects at an exercise price of 53.99 yuan per option [3][5]. Group 2: Reserved Stock Options - The reserved stock options will be granted on July 7, 2025, to 33 incentive objects, totaling 419,000 options at an exercise price of 53.49 yuan per option [4][6]. - The granting of reserved stock options is in accordance with the approved incentive plan and management regulations [6][8]. Group 3: Adjustment of Exercise Price - The exercise price for the stock options has been adjusted to 53.49 yuan per option due to the company's profit distribution plan [10]. - The adjustment complies with the provisions of the incentive plan and relevant regulations [10][11]. Group 4: Cancellation of Stock Options - The board approved the cancellation of 243,000 stock options held by 12 incentive objects who left the company for personal reasons [5]. - Additionally, 317,300 stock options were canceled due to the failure to meet performance conditions for the first exercise period [11]. - The cancellation of stock options aligns with the provisions of the incentive plan and management regulations [11].

证券代码：301488 证券简称：豪恩汽电 公告编号： 2025-036 深圳市豪恩汽车电子装备股份有限公司 关于调整 2024 年股票期权激励计划首次授予及预留授予行权价格的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 深圳市豪恩汽车电子装备股份有限公司（以下简称"公司"）于 2025 年 7 月 7 日召开了第三届董事会第十六次会议、第三届监事会第十三次会议，审议通过了 《关于调整 2024 年股票期权激励计划首次授予行权价格和预留授予行权价格的议 案》的议案，同意将公司 2024 年股票期权激励计划首次授予及预留授予的股票期 权行权价格调整为 53.49 元/股。现将有关事项说明如下： 一、已履行的相关审批程序 <2024 年股票期权激励计划（草案）>及其摘要的议案》《关于公司<2024 年股票期权激 励计划实施考核管理办法>的议案》及《关于提请股东大会授权董事会办理 2024 年股票 期权激励计划相关事宜的议案》。同日，公司召开第三届监事会第六次会议，审议通 过了《关于公司<2024 年股票期权激励计划（草案）>及其摘要的议案》《关于公司 <2 ...

深圳市豪恩汽车电子装备股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、监事会会议召开情况 深圳市豪恩汽车电子装备股份有限公司（以下简称"公司"）第三届监事会第十三次 会议通知于 2025 年 6 月 30 日通过电子邮件方式发出并送达全体监事。会议于 2025 年 出席监事 3 名，实际出席监事 3 名，会议由监事会主席陈特芳主持召开。本次会议的召 集、召开和表决程序符合《中华人民共和国公司法》等法律、行政法规、部门规章、规 范性文件和《深圳市豪恩汽车电子装备股份有限公司章程》的有关规定。 二、监事会会议审议情况 本次监事会审议通过并形成以下决议： （一）审议通过《关于 2024 年股票期权激励计划首次授予第一个行权期行权条件 未成就及注销部分股票期权的议案》 证券代码：301488 证券简称：豪恩汽电 公告编号：2025-034 表决情况：3 票赞成；0 票弃权；0 票反对。 （三）审议通过《关于向 2024 年股票期权激励计划激励对象授予预留股票期权的 议案》 经审核，监事会认为：董事会确定的预留授权日符合《上市公司股权激励管理办法》 和 ...

证券代码：601607 证券简称：上海医药 编号：临2025-068 上海医药集团股份有限公司 关于 2019 年 A 股股票期权激励计划预留股票期权第三个行 权期 2025 年第二季度自主行权结果公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 第三次会议，审议通过了《关于 2019 年股票期权激励计划（草案）及其摘要的 议案》（以下简称"《股票期权激励计划（草案）》"）、《关于 2019 年股票期权激 励计划实施考核管理办法的议案》（以下简称"《考核管理办法》"）、《关于提请 股东大会授权董事会办理 2019 年股票期权激励计划相关事宜的议案》。公司董事 中作为激励对象的关联董事左敏先生、李永忠先生及沈波先生均已回避表决。公 司独立董事基于独立客观判断，发表独立意见同意上述事项；公司监事会亦出具 核查意见。详见公司于 2019 年 10 月 1 日在指定信息披露媒体发布的相关公告。 于同意上海医药实施股票期权激励计划的批复》（沪国资委分配2019297 号）， 原则同意《股票期权激励计划（草案）》 ...

Group 1 - The core viewpoint of the news is that the Supervisory Board of Jebon Precision Technology Co., Ltd. has verified the eligibility of 64 individuals for the first vesting period of the restricted stock and stock options under the 2024 incentive plan, confirming compliance with relevant laws and regulations [1][2] - The first vesting conditions for the restricted stock have been met, allowing for the allocation of 266,700 shares to the eligible individuals [1] - The first exercise conditions for the stock options have also been met, permitting the exercise of 266,700 stock options for the eligible individuals [2] Group 2 - The verification process for both the restricted stock and stock options adheres to the provisions of the Company Law, Securities Law, and the Management Measures for Incentive Plans, ensuring no harm to the interests of the company and its shareholders [1][2] - The eligibility criteria for the incentive plan participants have been confirmed, with all 64 individuals meeting the necessary qualifications as per the relevant regulations [1][2]

Core Viewpoint - The company conducted a self-examination regarding the trading activities of insiders and incentive recipients related to the 2025 stock option incentive plan, confirming no insider trading occurred prior to the public announcement of the plan [1][3]. Group 1: Examination Process - The self-examination covered the period from December 16, 2024, to June 16, 2025, focusing on stock trading activities of insiders and incentive recipients [1]. - The examination was based on information provided by the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, which issued relevant certificates and detailed lists of share changes [2]. Group 2: Trading Activities of Insiders - Six individuals were identified as having engaged in stock trading during the examination period, with two being incentive recipients [2]. - The Chairman and General Manager, Chen Xueming, purchased shares as part of a previously disclosed increase plan, unrelated to insider information regarding the incentive plan [2]. - Other trading activities by five individuals, including two incentive recipients, were based on publicly disclosed information and independent market judgment, with no insider information influencing their trades [2][3]. Group 3: Conclusion of the Examination - The company found no evidence of information leakage or insider trading related to the incentive plan prior to its public disclosure [3]. - The company adhered to strict confidentiality measures and regulations during the planning and discussion phases of the incentive plan [3].

Core Viewpoint - The legal opinion letter from Beijing Zhonglun Law Firm confirms the cancellation of unexercised stock options under Perfect World Co., Ltd.'s stock option incentive plan, which is set to expire on July 2, 2025, following the necessary approvals and compliance with relevant regulations [1][6]. Group 1: Approval and Authorization - The company has completed the necessary procedures for the cancellation of unexercised stock options, including the approval of relevant proposals by the board of directors and independent directors [5][6]. - The independent directors have expressed their agreement to submit the stock option incentive plan to the shareholders' meeting for review [4][5]. Group 2: Specifics of the Cancellation - The stock option incentive plan has a validity period of 10 years, and any unexercised options will be voided upon expiration [6]. - A total of 37,460 stock options granted to 8 incentive targets will be canceled as they remain unexercised by the expiration date [6]. Group 3: Conclusion - The legal opinion concludes that the cancellation has obtained the necessary approvals and complies with the relevant regulations of the management measures and the stock option incentive plan [6].

Core Viewpoint - The company has announced the expiration and cancellation of unexercised stock options under its stock option incentive plan, which was effective for 10 years from July 3, 2015, to July 2, 2025 [1][2]. Summary by Sections Stock Option Incentive Plan - The stock option incentive plan was approved by the board and shareholders in 2015, with a validity period of 10 years [1]. - The exercise price of the stock options has been adjusted multiple times, with the final adjustment setting the price at 17.24 yuan per share [1]. Cancellation of Unexercised Stock Options - As of July 2, 2025, the company decided to cancel 37,460 stock options that were granted to 8 incentive recipients but remained unexercised [1]. - The cancellation aligns with the company's stock option incentive plan and relevant regulations [2]. Impact on the Company - The cancellation of the unexercised stock options is not expected to have a material impact on the company's financial status or operational results [1]. Opinions from Committees - The Board's Compensation and Assessment Committee and the Supervisory Committee both agree that the cancellation of the unexercised stock options complies with regulations and the company's incentive plan [2]. Legal Opinion - The legal opinion confirms that the necessary approvals and authorizations for the cancellation have been obtained, in accordance with relevant regulations [3].

新疆百花村医药集团股份有限公司 证券代码：600721 证券简称：百花医药 编号：2025-025 新疆百花村医药集团股份有限公司 2021 年股票期权激励计划 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要提示 ? 本次行权股票数量：2025 年 4 月 1 日至 2025 年 6 月 30 日，新疆百花村 医药集团股份有限公司（以下简称"公司"）2021 年股票期权激励计划首次 授予股票期权第三个行权期、预留授予股票期权第二个行权期激励对象共行权 并完成股份过户登记 149,540 股，占可行权股票期权总量的 5.90%。截至 2025 年 6 月 30 日累计行权并完成股份过户登记 2,205,445 股，占可行权股票期权总 量的 87.06%。 ? 本次行权股票上市流通时间：公司 2021 年股票期权激励计划采用自主行 权方式，激励对象行权股票于行权日（T 日）后第二个交易日（T+2）日上市 交易。 一、本次股票期权行权的决策程序及相关信息披露 通过《关于公司〈2021 年股票期权激励计划（草案）〉及其摘要的 ...